Technology Review - Published By MIT
Advertisement
TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.
I'm a paid subscriber please
log me in
I want to purchase this article for
only 99¢
(requires login)
I want to purchase five articles for
only $3.99
(requires login)
I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

November 2003

Heart Helper

An artery-opening balloon lowers the risk of angioplasty procedures.

By Technology Review

Opening clogged arteries with balloon angioplasty saves many heart patients' lives, but the procedure has its own risks. During surgery, bits of the gunk blocking the blood vessel may break off and can cause heart attacks. Velocimed of Minneapolis, MN, is seeking U.S. Food and Drug Administration approval for a system that could reduce that danger. In the system, the artery-opening balloon is inflated upstream of the blockage, so even if gunk breaks off, there's no moving blood to carry it downstream. The trick is a tunnel through the balloon that lets doctors insert a "stent" that props the artery open and suck out any loose material with a syringe before they remove the balloon. With traditional angioplasty, up to 16.5 percent of patients suffer cardiac events such as heart attacks within 30 days of stent placement. But in a small European trial, Velocimed's system reduced that risk to about 5.6 percent.

Select from the choices above
to read the entire article.


Log In

Forgot your password?     Register »
Advertisement

Videos

Laser-Triggered Chemical Reactions
Advertisement
Advertisement
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES

More Technology News from Forbes

Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.